Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne Martin

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Acta Neuropathologica|June 28, 2012
Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic studyMari Tada, Elizabeth A Coon, Alexander P Osmand, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2020
Is Levodopa Response a Valid Indicator of Parkinson's Disease?W R Wayne Martin, Michael Miles, Qiaonan Zhong, et al.
Annals of Neurology|November 4, 2022
Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not AlwaysW R Wayne Martin, John R Younce, Meghan C Campbell, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 7, 2012
Canadian Guidelines on Parkinson's DiseaseDavid Grimes, Joyce Gordon, Barbara Snelgrove, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Neurology|February 19, 2026
Contrast-Associated Acute Kidney Injury After Thrombectomy for Ischemic Stroke: Prognostic Impact and CAN-REST Predictive ScoreGhil Schwarz, Angelo Cascio Rizzo, Gareth Ambler, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Acta Neuropathologica|June 28, 2012
Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic studyMari Tada, Elizabeth A Coon, Alexander P Osmand, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2020
Is Levodopa Response a Valid Indicator of Parkinson's Disease?W R Wayne Martin, Michael Miles, Qiaonan Zhong, et al.
Annals of Neurology|November 4, 2022
Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not AlwaysW R Wayne Martin, John R Younce, Meghan C Campbell, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 7, 2012
Canadian Guidelines on Parkinson's DiseaseDavid Grimes, Joyce Gordon, Barbara Snelgrove, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Neurology|February 19, 2026
Contrast-Associated Acute Kidney Injury After Thrombectomy for Ischemic Stroke: Prognostic Impact and CAN-REST Predictive ScoreGhil Schwarz, Angelo Cascio Rizzo, Gareth Ambler, et al.
Pageof 12